Expect near-term pressure from the 9.3% discount and dilution. However, the $111M cash runway funds pivotal trials and the lock-up on 85.5% of shares reduces overhang. Watch for analyst reactions and the next clinical catalyst.
Price Chart
Executive Summary
GH Research PLC priced a follow-on offering of 6,527,779 ordinary shares at $18.00 per share, a 9.3% discount to the prior close of $19.85, raising net proceeds of approximately $111.2 million. The proceeds will fund R&D and general corporate purposes. The 10.5% dilution and the discount create near-term selling pressure, though the strong cash position and positive Phase 2b data support the long-term thesis.
Key Facts
- Offering of 6,527,779 ordinary shares at $18.00 per share
- Net proceeds of approximately $111.2 million
- Dilution of $12.30 per share for new investors (offering price minus adjusted net tangible book value of $5.70)
- Immediate post-offering shares outstanding: 68,557,174
- 30-day lock-up on 85.5% of shares held by insiders and major shareholders
Financial Impact
Approximately 10.5% dilution; $111.2 million raised, representing ~9.3% of market cap at offer price
Risk Factors
- Further dilution if additional equity needs arise
- Clinical trial setbacks could pressure stock
- High insider concentration (85.5%) limits free float
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001140361-26-017654 |
| Document: 0001140361-26-017654-index-headers.html | 0001140361-26-017654 |
| Document: 0001140361-26-017654-index.html | 0001140361-26-017654 |
| Document: 0001140361-26-017654.txt | 0001140361-26-017654 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | 6-K | $21.11 $18.15 | ▼ −14.02% | ▼ −12.05% | $19.18 (−9.14%) |
Sep 11, 2026 6w ago | 6-K | $27.20 $28.26 | ▲ +3.90% | ▲ +4.12% | $19.18 (−29.49%) |
Aug 6, 2026 11w ago | 6-K | $30.64 $28.19 | ▼ −8.00% | ▼ −9.21% | $19.18 (−37.40%) |
May 14, 2026 23w ago | 424B5 | $22.21 $21.77 | ▲ +1.98% | ▲ +1.26% | $19.18 (+13.64%) |
May 14, 2026 23w ago | 6-K | $22.21 $21.77 | ▼ −1.98% | ▼ −1.26% | $19.18 (−13.64%) |
May 14, 2026 23w ago | Press Release | $22.21 $21.77 | ▼ −1.98% | ▼ −1.26% | $19.18 (−13.64%) |
May 13, 2026 23w ago | 6-K | $22.21 $21.77 | ▲ +1.98% | ▲ +1.26% | $19.18 (+13.64%) |
Apr 29, 2026 25w ago | 424B5 | $19.16 $21.28 | ▼ −11.06% | ▼ −7.95% | $19.18 (−0.10%) |
Apr 1, 2026 29w ago | 3 | $14.57 $15.72 | ▲ +7.89% | ▲ +4.27% | $19.18 (+31.64%) |
Mar 25, 2026 30w ago | Press Release | $13.65 $14.72 | ▲ +7.84% | ▲ +8.08% | $19.18 (+40.51%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers